Recombinant Antibodies for In Vivo Use.
Bio X Cell RecombiMAb™ monoclonal antibodies are recombinant antibodies with the exact antigen-binding variable domains as the traditional antibodies they are derived from. The epitope to which the RecombiMAb™ antibody binds is identical to that of the matching traditionally produced clone. This is accomplished by sequencing and cloning the antibody-coding genes into high-yield expression vectors, which are then expressed in mammalian cells to generate the recombinant antibody.
Why Choose RecombiMAb™ Recombinant Antibodies?
Traditional monoclonal antibodies created using hybridoma technology are produced by fusing a B cell from an immunized animal with an immortalized myeloma cell. While this process produces highly specific and consistent monoclonal antibodies, it has some drawbacks. Hybridoma cells are susceptible to genetic drift, gene loss, and gene mutations, which can result in slight changes in binding specificity and antibody affinity over time. They also can sometimes express multiple productive antibody chains in which case they are not truly monoclonal.
While Bio X Cell’s optimized antibody manufacturing process utilizes multiple measures to avoid hybridoma genetic drift and lot-to-lot variability as much as is achievable, some levels are unavoidable. Further, since traditional hybridomas are created using immunized animals (typically rats or hamsters), the antibody species cannot be altered. This can be problematic when the species of the antibody does not match the species of the experimental animal. For example, injecting rat IgG into a mouse repeatedly over the course of an experiment can induce an immune response against the injected antibody in the mouse, leading to reduced antibody effectiveness and/or a hypersensitivity reaction. Recombinant antibodies do not suffer from these drawbacks.
RecombiMAb™ Features
Consistent and Highly Reproducible Data
RecombiMAb™ antibodies are derived from a defined DNA and amino acid sequence encoding only one heavy and one light chain. RecombiMAb™ antibodies are not susceptible to genetic drift, gene loss, or gene mutations. This ensures extremely high lot-to-lot consistency and data reproducibility from experiment to experiment.
Species Matching Chimerization
RecombiMAb™ antibodies are provided as chimeric antibodies with mouse or human IgG constant regions instead of the typical rat or hamster constant regions. This means improved in vivo activity and reduced immunogenicity in mouse models or humanized mouse models.
Available Fc Effector Function Modulation
Engaging Fc-mediated antibody effector functions through Fcγ receptor and complement interactions can be detrimental to certain antibody mechanisms of action. For example, antibodies that block cell surface receptors or cytokines do not require Fc-effector functions. This is especially important for immune checkpoint-blocking antibodies where target cell depletion is not desired.
Select RecombiMAb™ antibodies are available in multiple Fc-silenced versions. These Fc silenced versions have mutations in the antibody’s Fc fragment, rendering them unable to bind to endogenous Fcγ receptors or complement in vivo, thereby eliminating Fc-mediated antibody effector functions. Available Fc silencing mutations include D265A, S228P, and LALA-PG.
Formulated for in vivo Use
RecombiMAb™ antibodies are offered with the same purity and in vivo formulations that Bio X Cell is known for. Our recombinant antibodies are ultra-pure and free of preservatives, stabilizers, and carrier proteins, making them ideal for in vivo applications.
Binding Validation
Each lot of RecombiMAb™ product is validated for antigen binding by immunoblot.
Ultra-low Endotoxin Levels
The level of endotoxin is QC tested for each lot. Our RecombiMAb™ products are ≤ 1EU/mg. If endotoxin levels below 1EU/mg are required, please contact technical support to discuss your needs.
Pathogen Free
Each lot of RecombiMAb™ product is screened for an exhaustive panel of murine pathogens. The results are detailed in product-specific datasheets to help you adhere to IACUC and Animal Facility requirements.
Low Protein Aggregation
Each lot of RecombiMAb™ is QC tested for aggregate level and guaranteed to be below 5% of the total protein.
Meet Our Leaders
Learn more about the team behind the gold standard in vivo antibodies.
Discover Bio X Cell
Learn more about our proven expertise and comprehensive antibody solutions.
See Our Impact
Discover the Bio X Cell Fund’s mission to improve the health of our community
Explore Our Latest
See our latest articles and whitepapers for scientific insights and ideas
Consult With Bio X Cell to Enable Your Next Breakthrough Discovery
Whether you need antibody customization or high-volume production, Bio X Cell is committed to advancing your therapeutic innovations.
Contact Us